A nurse caring for a client”who has hypertension and asks the nurse about a prescription for propranolol. The nurse should inform the client that this medication is contraindicated in clients who have a history of which of the following conditions?

A) Temperature and respiratory rate:
While monitoring temperature and respiratory rate are important aspects of a comprehensive assessment, they are not the priority assessments before administering metoprolol. Metoprolol is a beta-blocker primarily used to lower heart rate and blood pressure, so assessing the client's heart rate and blood pressure is more relevant.

B) Heart rate and blood pressure:
This is the correct answer. Before administering metoprolol, it is essential to assess the client's heart rate and blood pressure. Metoprolol is a beta-blocker medication that primarily affects heart rate and blood pressure. Monitoring these vital signs helps ensure that the medication is administered safely and effectively.

C) Level of consciousness and pain level:
Assessing the client's level of consciousness and pain level are important aspects of nursing care, but they are not the priority assessments before administering metoprolol. These assessments may be relevant depending on the client's overall condition and specific care needs, but they are not directly related to the action or side effects of metoprolol.

D) Oxygen saturation and respiratory rate:
Monitoring oxygen saturation and respiratory rate are important aspects of respiratory assessment, but they are not the priority assessments before administering metoprolol. While metoprolol can affect respiratory function as a potential side effect, its primary action is on heart rate and blood pressure. Therefore, assessing heart rate and blood pressure are more pertinent before administering this medication.

A) STAT administration of atropine:
This is the correct answer. Atropine is a cholinergic antagonist that can increase heart rate by blocking the action of acetylcholine on cardiac muscarinic receptors. In cases of severe bradycardia, especially if associated with symptoms such as dizziness, syncope, or hypotension, atropine is often administered to increase heart rate and improve cardiac output. The dose of atropine and frequency of administration depend on the severity of bradycardia and the clinical response.

B) Administration of activated charcoal:
Activated charcoal is used in cases of overdose or poisoning to absorb ingested toxins and prevent their absorption into the bloodstream. However, in this scenario, where the primary concern is bradycardia resulting from cholinesterase inhibitor (donepezil) toxicity, activated charcoal would not be effective in reversing the bradycardic effects of the medication.

C) Hemodialysis:
Hemodialysis is a renal replacement therapy used to remove toxins and waste products from the blood in individuals with kidney failure. While hemodialysis may be indicated in cases of severe drug overdose or poisoning to enhance toxin elimination, it is not typically used as a first-line intervention for bradycardia associated with cholinesterase inhibitor toxicity.

D) Intravenous administration of pseudoephedrine:
Pseudoephedrine is a sympathomimetic drug that acts as a vasoconstrictor and can increase heart rate and blood pressure. While it may be used to treat bradycardia in some cases, such as severe symptomatic bradycardia unresponsive to atropine, it is not the first-line treatment for cholinesterase inhibitor toxicity-induced bradycardia. Atropine is preferred due to its direct antagonism of muscarinic receptors in the heart.